Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings Inc (NUTX)
:NUTX
NUTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.16 - $69.45
Previous CloseN/A
Volume3.28K
Average Volume (3M)43.81K
Market Cap
$335.19M
Enterprise Value$386.34M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.67
Next Earnings
Feb 27, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.86
Shares Outstanding5,437,003
10 Day Avg. Volume45,190
30 Day Avg. Volume43,808
Standard Deviation0.45
R-Squared0.06
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.15
Price to Cash Flow (P/CF)12.30
P/FCF Ratio3.90
Enterprise Value/Market Cap1.15
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.11
Enterprise Value/Ebitda48.59
Forecast
1Y Price Target
$75.00Price Target Upside30.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Clinigence Holdings News
PremiumCompany Announcements
Nutex Health Reports Strong Revenue Growth in Q3 2024
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionNutex opened its first ER Hospital in Odessa, FL, marking its initial entry into Florida — a market offering strong demand for ER services and a favorable regulatory environment.
Revenue GrowthWe expect NUTX to achieve a three-year compounded annual revenue growth rate of 16.6%, and achieve GAAP profitability in 3Q24.
Valuation OpportunityNUTX's shares currently trade at an EV/EBITDA multiple below the peer average, presenting an attractive valuation opportunity as the company executes its business strategy.
Bears Say
Financial PerformanceShares currently trade at an EV/revenue multiple of 0.4x our 2025 estimate, below the peer average of 1.6x, excluding NUTX.
Operational RisksThe typical US hospital and ER system is understaffed and burdened with overwhelming patient demand, which Nutex addresses with its micro-hospitals.
Profitability ConcernsThe company recognized a significant non-cash warrant liability expense, contributing to a worse-than-expected loss per share.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NUTX FAQ
What was Clinigence Holdings Inc’s price range in the past 12 months?
Clinigence Holdings Inc lowest stock price was $4.16 and its highest was $69.45 in the past 12 months.
What is Clinigence Holdings Inc’s market cap?
Clinigence Holdings Inc’s market cap is $335.19M.
When is Clinigence Holdings Inc’s upcoming earnings report date?
Clinigence Holdings Inc’s upcoming earnings report date is Feb 27, 2025 which is in 4 days.
How were Clinigence Holdings Inc’s earnings last quarter?
Clinigence Holdings Inc released its earnings results on Nov 07, 2024. The company reported -$1.72 earnings per share for the quarter, missing the consensus estimate of -$0.24 by -$1.48.
Is Clinigence Holdings Inc overvalued?
According to Wall Street analysts Clinigence Holdings Inc’s price is currently Undervalued.
Does Clinigence Holdings Inc pay dividends?
Clinigence Holdings Inc does not currently pay dividends.
What is Clinigence Holdings Inc’s EPS estimate?
Clinigence Holdings Inc’s EPS estimate is -0.12.
How many shares outstanding does Clinigence Holdings Inc have?
Clinigence Holdings Inc has 5,437,003 shares outstanding.
What happened to Clinigence Holdings Inc’s price movement after its last earnings report?
Clinigence Holdings Inc reported an EPS of -$1.72 in its last earnings report, missing expectations of -$0.24. Following the earnings report the stock price went up 9.242%.
Which hedge fund is a major shareholder of Clinigence Holdings Inc?
Currently, no hedge funds are holding shares in NUTX
---
Clinigence Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$75.00 (30.21% Upside)
$75.00 (30.21% Upside)
Blogger Sentiment
Bullish
NUTX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 222.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 11.5%
Last 30 Days ▼ 11.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
225.42%
12-Months-Change
Fundamentals
Return on Equity
-54.71%
Trailing 12-Months
Asset Growth
-8.58%
Trailing 12-Months
Company Description
Clinigence Holdings Inc
Clinigence Holdings, Inc. is a healthcare information technology company. It provides cloud-based platform that enables healthcare organizations to provide value-based care and population health management. The company was founded in 2018 and is headquartered in Atlanta, GA.
---
NUTX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with notable revenue and EBITDA growth, alongside improvements in operational efficiency and cash flow. However, challenges remain with increased net losses and a decline in the Population Health division revenue. The company's strategic initiatives and cost control measures show promise for future performance.Read More>---
NUTX Stock 12 Month Forecast
Average Price Target
$75.00
▲(30.21% Upside)
Technical Analysis
Best Analysts Covering NUTX
1 Year
1 Year Success Rate
4/9 ratings generated profit
1 Year Average Return
+75.26%
assigned a buy rating 3 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +75.26% per trade.
---